Correction to: Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment (The AAPS Journal, (2018), 20, 1, (25), 10.1208/s12248-017-0181-6)

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the published article, the author B. Babbitt was cited as affiliation 9, but should have been cited as affiliation 2. In addition, there are 2 errors in the affiliations. The correct affiliations are shown in this erratum.

Cited by Powered by Scopus

MB09, a denosumab biosimilar candidate: Biosimilarity demonstration in a phase I study in healthy subjects

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gouty, D., Cai, C. C., Cai, X. Y., Kasinath, A., Kumar, V., Alvandkouhi, S., … Satterwhite, C. (2018, March 1). Correction to: Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment (The AAPS Journal, (2018), 20, 1, (25), 10.1208/s12248-017-0181-6). AAPS Journal. Springer New York LLC. https://doi.org/10.1208/s12248-018-0189-6

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

100%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 2

67%

Biochemistry, Genetics and Molecular Bi... 1

33%

Save time finding and organizing research with Mendeley

Sign up for free